The immunodominant influenza a virus M158-66 cytotoxic t lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10613-10623

  Choo, Joanna A L ^a   Liu, Jingxian ^b   Toh, Xinyu ^b   Grotenbreg, Gijsbert M ^a   Ren, Ee Chee ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA C ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN M1 58 66; UNCLASSIFIED DRUG; VIRUS PROTEIN; M1 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN;

ALPHA HELIX; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; GENE FREQUENCY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYDROGEN BOND; IMMUNOGENICITY; INFLUENZA VIRUS A; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VACCINE PRODUCTION; VIRUS IMMUNITY; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; IMMUNOLOGY; INFLUENZA; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; VIROLOGY;

AMINO ACID SEQUENCE; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HLA-C ANTIGENS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON-GAMMA; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EID: 84906350543     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00855-14     Document Type: Article

References (39)

1. Webster RG, Wright SM, Castrucci MR, Bean WJ, Kawaoka Y. 1993. Influenza-a model of an emerging virus disease. Intervirology 35:16-25.
2. Yap KL, Ada GL, McKenzie IF. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273: 238-239. http://dx.doi.org/10.1038/273238a0.
3. McMichael AJ, Gotch FM, Noble GR, Beare PA. 1983. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309:13-17. http://dx.doi.org/10.1056/NEJM198307073090103.
4. Guo H, Santiago F, Lambert K, Takimoto T, Topham DJ. 2011. T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J. Virol. 85:448-455. http://dx.doi.org /10.1128/JVI.01812-10.
5. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, Bean T, Barclay W, Deeks JJ, Lalvani A. 2013. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19:1305-1312. http://dx.doi.org/10.1038/nm.3350.
6. Lee LY-H, Ha DLA, Simmons C, de Jong MD, Chau NVV, Schumacher R, Peng Y-C, McMichael AJ, Farrar JJ, Smith GL, Townsend ARM, Askonas BA, Rowland-Jones S, Dong T. 2008. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118:3478-3490. http://dx.doi.org/10.1172/JCI32460.
7. + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc. Natl. Acad. Sci. U. S. A. 107:12599-12604. http://dx.doi.org/10.1073/pnas.1007270107.
8. Laurie KL, Carolan LA, Middleton D, Lowther S, Kelso A, Barr IG. 2010. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J. Infect. Dis. 202:1011-1020. http://dx.doi.org/10.1086/656188.
9. + T-cell immunity to the H7N9 influenza A virus varies across ethnicities. Proc. Natl. Acad. Sci. U. S. A. 111:1049-1054. http://dx.doi.org/10.1073/pnas.1322229111.
10. Doolan DL, Hoffman SL, Southwood S, Wentworth PA, Sidney J, Chesnut RW, Keogh E, Appella E, Nutman TB, Lal AA, Gordon DM, Oloo A, Sette A. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7:97-112. http://dx.doi.org/10.1016/S1074-7613(00)80513-0.
11. Threlkeld SC, Wentworth PA, Kalams SA, Wilkes BM, Ruhl DJ, Keogh E, Sidney J, Southwood S, Walker BD, Sette A. 1997. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. J. Immunol. 159:1648-1657.
12. Kondo E, Akatsuka Y, Kuzushima K, Tsujimura K, Asakura S, Tajima K, Kagami Y, Kodera Y, Tanimoto M, Morishima Y, Takahashi T. 2004. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. Blood 103:630-638. http://dx.doi.org/10.1182/blood-2003 -03-0824.
13. Burrows SR, Elkington RA, Miles JJ, Green KJ, Walker S, Haryana SM, Moss DJ, Dunckley H, Burrows JM, Khanna R. 2003. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype. J. Immunol. 171: 1407-1412. http://dx.doi.org/10.4049/jimmunol.171.3.1407.
14. + T-cell response in a Northern Chinese population. Tissue Antigens 62:285-295. http://dx.doi.org/10.1034/j.1399-0039.2003.00102.x.
15. Liu J, Zhang S, Tan S, Yi Y, Wu B, Cao B, Zhu F, Wang C, Wang H, Qi J, Gao GF. 2012. Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals. J. Virol. 86:13281-13294. http://dx.doi.org/10.1128/JVI.01841-12.
16. Currier JR, deSouza M, Chanbancherd P, Bernstein W, Birx DL, Cox JH. 2002. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles. J. Virol. 76:4971- 4986. http://dx.doi.org/10.1128/JVI.76.10.4971-4986.2002.
17. + T cell epitopes identified in US adolescent minorities. J. Acquir. Immune Defic. Syndr. 33:426-438. http://dx.doi.org/10.1097/00126334-200308010-00003.
18. Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, Barkhan D, Puren A, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM, HIVNET 028 Study Team. 2004. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J. Immunol. 173:4607-4617. http://dx.doi.org/10.4049/jimmunol.173.7.4607.
19. Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J, Hraber P, Hewitt HS, Linde CH, Kavanagh DG, Woodberry T, Henry LM, Faircloth K, Listgarten J, Kadie C, Jojic N, Sango K, Brown NV, Pae E, Zaman MT, Bihl F, Khatri A, John M, Mallal S, Marincola FM, Walker BD, Sette A, Heckerman D, Korber BT, Brander C. 2007. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur. J. Immunol. 37:2419-2433. http://dx.doi.org/10.1002/eji.200737365.
20. Gotch F, Rothbard J, Howland K, Townsend A, McMichael A. 1987. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326:881-882. http://dx.doi.org/10.1038/326881a0.
21. Morrison J, Elvin J, Latron F, Gotch F, Moots R, Strominger JL, McMichael A. 1992. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur. J. Immunol. 22:903-907. http://dx.doi.org /10.1002/eji.1830220404.
22. Garboczi DN, Hung DT, Wiley DC. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. U. S. A. 89:3429-3433. http://dx.doi.org/10.1073/pnas.89.8.3429.
23. Stura EA, Wilson IA. 1991. Applications of the streak seeding technique in protein crystallization. J. Crystal Growth 110:270-282. http://dx.doi.org/10.1016/0022-0248(91)90896-D.
24. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AGW, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, Read RJ, Vagin A, Wilson KS. 2011. Overview of the CCP4 suite and current developments. Acta Crystallogr.DBiol. Crystallogr. 67:235-242. http://dx.doi.org /10.1107/S0907444910045749.
25. Laskowski RA, Moss DS, Thornton JM. 1993. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231:1049-1067. http: //dx.doi.org/10.1006/jmbi.1993.1351.
26. Delano WL. 2002. The PyMOL molecular graphics system. DeLano Scientific LLC, Palo Alto, CA.
27. Krissinel E, Henrick K. 2007. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372:774-797. http://dx.doi.org/10.1016/j.jmb.2007.05.022.
28. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A. 2000. Human memory CTL response specific for influenza A virus is broad and multispecific. Hum. Immunol. 61:438-452. http://dx.doi.org/10.1016/S0198 -8859(00)00105-1.
29. Alexander J, Bilsel P, del Guercio M-F, Marinkovic-Petrovic A, Southwood S, Stewart S, Ishioka G, Kotturi MF, Botten J, Sidney J, Newman M, Sette A. 2010. Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus. Hum. Immunol. 71:468-474. http://dx.doi.org/10.1016/j.humimm.2010.02.014.
30. Barouch D, Friede T, Stevanović S, Tussey L, Smith K, Rowland-Jones S, Braud V, McMichael A, Rammensee HG. 1995. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182:1847-1856. http://dx.doi.org/10.1084/jem.182.6.1847.
31. van Buuren MM, Dijkgraaf FE, Linnemann C, Toebes M, Chang CXL, Mok JY, Nguyen M, van Esch WJE, Kvistborg P, Grotenbreg GM, Schumacher TNM. 2014. HLA micropolymorphisms strongly affect peptide-MHCmultimer-based monitoring of antigen-specificCD8+Tcell responses. J. Immunol. 192:641-648. http://dx.doi.org/10.4049/jimmunol.1301770.
32. Boon ACM, de Mutsert G, Graus YMF, Fouchier RAM, Sintnicolaas K, Osterhaus ADME, Rimmelzwaan GF. 2002. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J. Virol. 76:582-590. http: //dx.doi.org/10.1128/JVI.76.2.582-590.2002.
33. Lam TH, Shen M, Chia J-M, Chan SH, Ren EC. 2013. Populationspecific recombination sites within the human MHC region. Heredity (Edinb.) 111:131-138. http://dx.doi.org/10.1038/hdy.2013.27.
34. Trachtenberg E, Vinson M, Hayes E, Hsu Y-M, Houtchens K, Erlich H, Klitz W, Hsia Y, Hollenbach J. 2007. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 70:455-463. http://dx.doi.org/10.1111/j.1399-0039.2007.00932.x.
35. Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, Gao X, Cozen W, Rothman N, Davis S, Severson RK, Bernstein L, Hartge P, Carrington M. 2010. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood 115:4820-4823. http://dx.doi.org/10.1182/blood-2010-01-266775.
36. + T-cell responses in acute and chronic viral diseases. Eur. J. Immunol. 43:1109-1120. http://dx.doi.org /10.1002/eji.201243088.
37. Tan AT, Sodsai P, Chia A, Moreau E, Chng MHY, Tham CYL, Ho ZZ, Banu N, Hirankarn N, Bertoletti A. 2014. Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region. J. Virol. 88:1332- 1341. http://dx.doi.org/10.1128/JVI.02600-13.
38. Bertoni R, Sidney J, Fowler P, Chesnut RW, Chisari FV, Sette A. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100:503-513. http://dx.doi.org/10.1172/JCI119559.
39. Thimme R, Chang KM, Pemberton J, Sette A, Chisari FV. 2001. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51. J. Virol. 75:3984-3987. http://dx.doi.org/10.1128/JVI.75.8.3984-3987.2001.